A1 Refereed original research article in a scientific journal
Casting vs Surgical Treatment of Children With Medial Epicondyle Fractures
Authors: Grahn, Petra; Helenius, Ilkka; Hämäläinen, Tero; Kivisaari, Reetta; Nietosvaara, Yrjänä; Sinikumpu, Juha-Jaakko; Jalkanen, Jenni; Löyttyniemi, Eliisa; Ahonen, Matti; Finnish Pediatric Orthopedic Study Group Investigators
Publisher: American Medical Association (AMA)
Publishing place: CHICAGO
Publication year: 2025
Journal: JAMA Network Open
Journal name in source: JAMA Network Open
Journal acronym: JAMA NETW OPEN
Article number: e258479
Volume: 8
Issue: 5
Number of pages: 12
ISSN: 2574-3805
eISSN: 2574-3805
DOI: https://doi.org/10.1001/jamanetworkopen.2025.8479
Web address : https://doi.org/10.1001/jamanetworkopen.2025.8479
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/498496832
Importance: Displaced pediatric medial humeral epicondyle fractures are traditionally treated nonoperatively with casting. However, the use of surgical treatment has increased despite limited high-level evidence supporting its benefits.
Objective: To determine whether open surgical reduction and internal fixation improve functional outcomes compared with long arm casting in children with displaced medial humeral epicondyle fractures at 12 months post injury.
Design, setting, and participants: This noninferiority randomized clinical trial was conducted in 4 university hospitals in Finland between August 30, 2019, and August 22, 2023, with a 12-month follow-up completed August 20, 2024. Participants included children (aged 7-16 years) with nonincarcerated medial humeral epicondyle fractures and more than 2 mm of displacement. Data analysis was based on intention to treat.
Interventions: Open reduction and fixation, followed by a long arm cast for 4 weeks, or long arm cast without reduction for 4 weeks.
Main outcome and measure: The primary outcome was the Quick Disabilities of the Arm, Shoulder, and Hand (QDASH) score at 12 months (range, 0-100 points, with 0 denoting no disability and 100 extreme disability; prespecified noninferiority margin was 6.8 points).
Results: Seventy-two patients were randomized (43 [59.7%] female; mean [SD] age, 12.1 [2.1] years; range, 7.9-15.9 years), with 37 (19 [51.4%] female) to the surgery group (mean [SD] age, 12.2 [2.3] years; range, 7.9-15.9 years) and 35 (24 [68.6%] female) to the cast group (mean [SD] age, 11.9 [2.0] years; range 7.9-15.9 years). At 12 months, the mean QDASH score was 1.73 (95% CI, 0.65-2.81) in the surgery group and 2.71 (95% CI, 0.52-4.90) in the cast group, showing noninferiority (mean difference, -0.98 [95% CI, -2.95 to 0.98] points). The cosmetic visual analog scale favored the cast group, with a statistically significant between-group difference of -8.9 points (95% CI, -16.6 to -1.2 points; P < .001). Nonunion occurred in 1 of 37 surgically treated patients (2.7%) and 24 of 35 cast-treated patients (68.6%). No crossovers from casting to surgery occurred.
Conclusions and relevance: In this randomized clinical trial of displaced medial epicondyle fractures, treatment with casting alone was noninferior at 12 months to surgical reduction and internal fixation followed by casting. Findings support nonoperative care as effective at 1 year; longer-term outcomes remain to be studied.
Trial RegistrationClinicalTrials.gov Identifier: NCT04531085
Downloadable publication This is an electronic reprint of the original article. |
Funding information in the publication:
This study was supported by the Finnish State Funding through Helsinki and Turku University Hospitals, the University of Helsinki Research Funding for Injuries and Rehabilitation, the Paivikki and Sakari Sohlberg Foundation, and the Finnish Paediatric Research Foundation. The funding was allocated solely for researchers' salaries.